Cupid reports record Q3, eyes GCC expansion with Saudi FMCG facility
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
Cupid is strengthening its footprint in the GCC region, focusing on supply responsiveness and market proximity
The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer
Applications include detailed scientific rationale and supporting clinical evidence
Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals
CuraTeQ Biologics and BioFactura USA to terminate agreement mutually
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
AFib is a progressive condition where timely intervention is critical to disease management and, ultimately, the patient's quality of life
The drug is designed to improve functional capacity and reduce symptoms by inhibiting cardiac myosin motor activity
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
Subscribe To Our Newsletter & Stay Updated